SEC 13F Intelligence

Roumell Asset Management, LLC / BCDA

Roumell Asset Management, LLC’s Biocardia Inc Position

Does Roumell Asset Management, LLC own Biocardia Inc (BCDA)? Not currently — the last reported position was 536.5K shares worth $1M in Q1 2022; the fund’s latest 13F (Q2 2024) no longer reports it.

Position Value
$1M
Q1 2022
Shares
536.5K
% of Portfolio
+1.80%
Quarters Held
8
position exited

Position History BCDA

Reported value by quarter
Q2 ’20: $796,000Q2 ’20Q3 ’20: $756,000Q3 ’20Q4 ’20: $2MQ4 ’20Q1 ’21: $5MQ1 ’21Q2 ’21: $5MQ2 ’21Q3 ’21: $3MQ3 ’21Q4 ’21: $2MQ4 ’21Q1 ’22: $1MQ1 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2022536.5K$1M+1.80%
Q4 2021938.4K$2M+2.43%
Q3 2021938.4K$3M+3.90%
Q2 20211.26M$5M+5.83%
Q1 20211.26M$5M+7.89%
Q4 2020565.1K$2M+3.07%
Q3 2020333.0K$756,000+1.50%
Q2 2020333.0K$796,000+1.92%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Roumell Asset Management, LLC’s full portfolio or all institutional holders of BCDA.